Paper874697
The pharmacokinetics of amikacin in children.
Vogelstein B and 2 others. J Pediatr, 1977. Cited by 65 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. The pharmacokinetics of amikacin in children. Papers, record 874697. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/874697
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Amikacin | Major topic |
| Kanamycin | Major topic |
| Metabolic Clearance Rate | Major topic |
| Adolescent | |
| Anemia, Aplastic | |
| Appendicitis | |
| Child | |
| Child, Preschool | |
| Cystic Fibrosis | |
| Female | |
| Half-Life | |
| Humans | |
| Kidney | |
| Leukemia | |
| Male | |
| Neoplasms | |
| Neutropenia | |
| Pelvic Inflammatory Disease |
Source PubMed
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 65 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39435440 | Prediction of tissue exposures of polymyxin-B, amikacin and sulbactam using physiologically-based pharmacokinetic modeling. | Front Microbiol | 2024 | https://conductscience.org/library/papers/39435440 | PubMed |
| 34185905 | Predictive Performance of Physiology-Based Pharmacokinetic Dose Estimates for Pediatric Trials: Evaluation With 10 Bayer Small-Molecule Compounds in Children. | J Clin Pharmacol | 2021 | https://conductscience.org/library/papers/34185905 | PubMed |
| 33498481 | Population Pharmacokinetics Analysis of Amikacin Initial Dosing Regimen in Elderly Patients. | Antibiotics (Basel) | 2021 | https://conductscience.org/library/papers/33498481 | PubMed |
| 26801317 | Prediction of Human Glomerular Filtration Rate from Preterm Neonates to Adults: Evaluation of Predictive Performance of Several Empirical Models. | AAPS J | 2016 | https://conductscience.org/library/papers/26801317 | PubMed |
| 21190043 | Renal function in pediatric cystic fibrosis patients in the first decade of life. | Pediatr Nephrol | 2011 | https://conductscience.org/library/papers/21190043 | PubMed |
| 9884816 | Pharmacokinetic optimisation of antibacterial treatment in patients with cystic fibrosis. Current practice and suggestions for future directions. | Clin Pharmacokinet | 1998 | https://conductscience.org/library/papers/9884816 | PubMed |
| 8055682 | Pharmacokinetics of anti-infective agents in paediatric patients. | Clin Pharmacokinet | 1994 | https://conductscience.org/library/papers/8055682 | PubMed |
| 7327659 | Newer antibiotics. | Indian J Pediatr | 1981 | https://conductscience.org/library/papers/7327659 | PubMed |
| 7140805 | Modification in the pharmacokinetics of amikacin during development. | Eur J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/7140805 | PubMed |
| 4083865 | Pharmacokinetics and dosage requirements of netilmicin in cystic fibrosis patients. | Antimicrob Agents Chemother | 1985 | https://conductscience.org/library/papers/4083865 | PubMed |
| 3780832 | Pharmacokinetics of amikacin in cystic fibrosis: a study of bronchial diffusion. | Eur J Clin Pharmacol | 1986 | https://conductscience.org/library/papers/3780832 | PubMed |
| 3319914 | High dose treatment with antibiotics in cystic fibrosis--a reappraisal with special reference to the pharmacokinetics of beta-lactams and new fluoroquinolones in adult CF-patients. | Infection | 1987 | https://conductscience.org/library/papers/3319914 | PubMed |
| 3311531 | Antibiotic pharmacokinetics in cystic fibrosis. Differences and clinical significance. | Clin Pharmacokinet | 1987 | https://conductscience.org/library/papers/3311531 | PubMed |
| 3293970 | Clinical pharmacology of antibiotics and other drugs in cystic fibrosis. | Drugs | 1988 | https://conductscience.org/library/papers/3293970 | PubMed |
| 3117703 | Kinetic parameters of amikacin in cystic fibrosis children. | Infection | 1987 | https://conductscience.org/library/papers/3117703 | PubMed |
| 3042246 | Influence of the glomerular filtration rate on renal clearance of ceftazidime in cystic fibrosis. | Clin Pharmacokinet | 1988 | https://conductscience.org/library/papers/3042246 | PubMed |
| 2802567 | Pharmacokinetics of amikacin in hematologic malignancies. | Antimicrob Agents Chemother | 1989 | https://conductscience.org/library/papers/2802567 | PubMed |
| 2327775 | Amikacin pharmacokinetics and suggested dosage modifications for the preterm infant. | Antimicrob Agents Chemother | 1990 | https://conductscience.org/library/papers/2327775 | PubMed |
| 533263 | Amikacin pharmacokinetics in pediatric patients with malignancy. | Antimicrob Agents Chemother | 1979 | https://conductscience.org/library/papers/533263 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/874697
GET https://conductscience.org/api/papers/v1/874697/authors